Inventory Forecasting for Peptide Companies — Beyond Reordering When You Hit Zero
Reactive reordering guarantees stockouts because lead times are never instant. This guide covers building a forecasting system that orders ahead of demand instead of chasing behind it.
Most early-stage peptide founders manage inventory reactively — reordering once stock visibly runs low or hits zero. This works until order volume grows enough that lead times start mattering more than intuition, at which point reactive ordering reliably produces stockouts.
Calculating Sell-Through Velocity
The foundation of forecasting is knowing how quickly each product actually sells — units per week or month, tracked per SKU rather than as an aggregate. This number, not gut feel, should drive every reorder decision.
Setting Reorder Thresholds Around Lead Time
Once sell-through velocity is known, the reorder point should be set high enough that a new order, placed today, arrives before existing stock runs out — accounting for the supplier's actual lead time, not an optimistic estimate of it.
Avoiding the Overstock Trap
Forecasting isn't only about preventing stockouts — ordering too far ahead ties up capital in inventory that may sit for months, especially for lower-velocity SKUs. The goal is a reorder point and quantity that minimizes both stockout risk and excess capital tied up in slow-moving stock.
Accepting Crypto Payments for a Peptide Business in 2026 — The Complete Operator Guide
How to accept crypto payments for a peptide business in 2026. Stablecoin settlement, avoiding volatility, payment redundancy, and why crypto is the most chargeback-proof rail.
Fulfillment Operations for Peptide Companies — Why Most Founders Get This Wrong First
Delayed orders are the single fastest way to lose customer trust in a restricted industry. This guide covers the operational structure that prevents fulfillment from becoming the bottleneck that breaks an otherwise good brand.
Customer Support Systems for Peptide Companies — Scaling Past Founder-Led Support
Most peptide founders start by answering every support message personally. That works at low volume and breaks completely once order volume grows. Here's how to build a system that scales before it becomes urgent.